Sudeep Pharma Ltd
NSE:SUDEEPPHRM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sudeep Pharma Ltd
NSE:SUDEEPPHRM
|
IN |
|
R
|
RWE AG
PSE:RWE
|
DE |
|
Y
|
Ypsomed Holding AG
XMUN:OWX
|
CH |
|
I
|
Ionis Pharmaceuticals Inc
XMUN:ISI
|
US |
Wall St Price Targets
SUDEEPPHRM Price Targets Summary
Sudeep Pharma Ltd
According to Wall Street analysts, the average 1-year price target for SUDEEPPHRM is 793.05 INR with a low forecast of 707 INR and a high forecast of 897.75 INR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SUDEEPPHRM's stock price target?
Price Target
793.05
INR
According to Wall Street analysts, the average 1-year price target for SUDEEPPHRM is 793.05 INR with a low forecast of 707 INR and a high forecast of 897.75 INR.
What is the Revenue forecast for Sudeep Pharma Ltd?
Projected CAGR
22%
Over the last 3 years, the compound annual growth rate for Revenue has been 14%. The projected CAGR for the next 2 years is 22%.
What is the Operating Income forecast for Sudeep Pharma Ltd?
Projected CAGR
16%
Over the last 3 years, the compound annual growth rate for Operating Income has been 38%. The projected CAGR for the next 2 years is 16%.
What is the Pre-Tax Income forecast for Sudeep Pharma Ltd?
Projected CAGR
14%
Over the last 3 years, the compound annual growth rate for Pre-Tax Income has been 38%. The projected CAGR for the next 2 years is 14%.
What is the Net Income forecast for Sudeep Pharma Ltd?
Projected CAGR
15%
Over the last 3 years, the compound annual growth rate for Net Income has been 41%. The projected CAGR for the next 2 years is 15%.
